Delivery Order SPE2DB22D1103-SPE2DB25FTRN1
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of Lisdexamfetamine 70 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order valued at $5,456.55 with a firm fixed price, and has an ultimate completion date of June 11,...
- This is a $1,972.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 30 mg capsules, which are a pharmaceutical product used to treat conditions such as ADHD. The contract has an ultimate completion date of July 8, 2025 and does not have a set-aside designation, indicating it was competitively awarded....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,950.18, is for the delivery of Lisdexamfetamine 60 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price and an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lisdexamfetamine 30 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $8,520.42 and a performance period extending through June 2025. This is a firm fixed-price contract without any set-aside...
- This federal contract award, valued at $7,192.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 30 mg capsules, a medication used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The contract has a completion date of February 28, 2025 and is structured as a Firm Fixed Price Delivery Order. AmerisourceBergen holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,100.64 and a completion date of June 24, 2025. The contract provides for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 60 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed-price pricing type and a ceiling value of $4,008.24. The contract does not have a set-aside designation, indicating open...
- This federal contract award, valued at $2,853.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 20 mg capsules, a medication used to treat ADHD, with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 100 capsules of the drug Lisdexamfetamine 50 mg, a prescription medication used to treat conditions such as attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,229.87 and a period of performance through July 1, 2025. The contract is not set...
- This federal contract award, valued at $5,188.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the medication Lisdexamfetamine 50 mg capsule, a treatment used for conditions such as ADHD. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 30, 2025. Amerisourcebergen Drug Corp is the prime contractor,...